Na+,-K+-ATPase Deficiency Exacerbates Cardiac Fibrosis via Promoting ERRα-Mediated Myocardial Cell Injury and

Ting Lei1, Tao Liu1,2, Yutong Liu2

  • 1Department of Clinical Laboratory, Xi'an People's Hospital (Xi'an Fourth Hospital), 710004 Xi'an, Shaanxi, China.

Insights

Na+, K+-ATPase (NKA) α1 deficiency worsens cardiac fibrosis by increasing inflammation and cell death. Targeting the NKAα1 DR-region may offer a novel therapeutic strategy for heart disease.

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Immunology

Background:

  • Inflammation is a key driver of tissue fibrosis.
  • Na+, K+-ATPase (NKA) α1 deficiency impairs mitochondrial function and cardiac remodeling.
  • This study investigates the link between inflammation and NKAα1 deficiency in cardiac fibrosis.

Purpose of the Study:

  • To elucidate the role of NKAα1 deficiency in inflammation-driven cardiac fibrosis.
  • To understand the mechanisms underlying NKAα1 deficiency-induced cardiac remodeling.
  • To identify potential therapeutic targets for cardiac fibrosis.

Main Methods:

  • Utilized a mouse model with NKAα1 haploinsufficiency subjected to isoproterenol (ISO) challenge.
  • Performed histopathology, electron microscopy, RT-qPCR, immunoblotting, and ELISA.
  • Employed a cell co-culture system to study cell interactions.

Main Results:

  • NKAα1 deficiency exacerbated ISO-induced cardiac fibrosis, macrophage infiltration, and inflammatory markers.
  • NKAα1 deficiency accelerated cardiomyocyte death and amplified intercellular crosstalk, promoting inflammation and fibrosis.
  • Estrogen-related receptor α (ERRα) mediated cardiomyocyte death and IL-18 release; a DR-region antibody reduced fibrosis.

Conclusions:

  • NKAα1 deficiency exacerbates cardiac fibrosis via ERRα-dependent cardiomyocyte death and enhanced cell communication.
  • NKAα1 deficiency facilitates crosstalk between cardiomyocytes, macrophages, and fibroblasts, driving fibrosis.
  • NKAα1 and its DR-region are potential therapeutic targets for cardiac fibrosis.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.2K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40